School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.
COPD. 2021 Aug;18(4):469-475. doi: 10.1080/15412555.2021.1945021. Epub 2021 Jul 5.
Healthcare access and delivery for individuals with chronic obstructive pulmonary disease (COPD) who live in remote areas or who are susceptible to contracting communicable diseases, such as COVID-19, may be a challenge. Telehealth and remote monitoring devices can be used to overcome this issue. However, the accuracy of these devices must be ensured before forming healthcare decisions based on their outcomes. Therefore, a systematic review was performed to synthesize the evidence on the reliability, validity and responsiveness of digital devices used for tracking oxygen saturation (SpO) and/or respiratory rate (RR) in individuals with COPD, in remote settings. Three electronic databases were searched: MEDLINE (1996 to October 8, 2020), EMBASE (1996 to October 8, 2020) and CINAHL (1998 to October 8, 2020). Studies were included if they aimed to evaluate one or more measurement properties of a digital device measuring SpO or RR in individuals with COPD. Six-hundred and twenty-five articles were identified and after screening, 7 studies matched the inclusion criteria; covering 11 devices measuring SpO and/or RR. Studies reported on the reliability ( = 1), convergent validity ( = 1), concurrent validity ( = 2) and predictive validity ( = 2) of SpO devices and on the convergent validity ( = 1), concurrent validity ( = 1) and predictive validity ( = 1) of RR devices. SpO and RR devices were valid when compared against other respiration monitoring devices but were not precise in predicting exacerbation events. More well-designed measurement studies are needed to make firm conclusions about the accuracy of such devices.Supplemental data for this article is available online at https://doi.org/10.1080/15412555.2021.1945021 .
在偏远地区或易感染传染病(如 COVID-19)的慢性阻塞性肺疾病(COPD)患者的医疗保健获取和提供可能是一个挑战。远程医疗和远程监测设备可用于克服这一问题。然而,在基于这些设备的结果制定医疗保健决策之前,必须确保这些设备的准确性。因此,进行了一项系统评价,以综合在偏远地区使用数字设备来跟踪 COPD 患者的血氧饱和度(SpO)和/或呼吸频率(RR)的可靠性、有效性和响应性的证据。在三个电子数据库中进行了搜索:MEDLINE(1996 年至 2020 年 10 月 8 日),EMBASE(1996 年至 2020 年 10 月 8 日)和 CINAHL(1998 年至 2020 年 10 月 8 日)。如果研究旨在评估一种或多种数字设备测量 SpO 或 RR 的一种或多种测量特性,则将其纳入研究。共确定了 625 篇文章,经过筛选,有 7 项研究符合纳入标准;共涉及 11 种测量 SpO 和/或 RR 的设备。研究报告了 SpO 设备的可靠性( = 1)、收敛有效性( = 1)、同期有效性( = 2)和预测有效性( = 2),以及 RR 设备的收敛有效性( = 1)、同期有效性( = 1)和预测有效性( = 1)。当与其他呼吸监测设备进行比较时,SpO 和 RR 设备是有效的,但在预测恶化事件方面并不精确。需要进行更多设计良好的测量研究,以对这些设备的准确性得出确切结论。https://doi.org/10.1080/15412555.2021.1945021 提供了本文的补充数据。